Philip Morris International Inc. (PM)
Unveiling Philip Morris (PM) Q3 Outlook: Wall Street Estimates for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for Philip Morris (PM), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2024.
Philip Morris Is Only Getting Started: Earnings Preview
Philip Morris has outperformed the S&P 500 with a 32% YTD return, driven by strong sales of HTUs and ZYN nicotine pouches. Despite this performance, the stock trades at a 24% valuation discount to SPY. Analysts expect Q3 revenue of $9.69 billion and $1.82 non-GAAP EPS, with Philip Morris historically beating estimates 80% of the time or more over the last 5 years.
Building A Portfolio Of Leaders With Philip Morris
PM is set to enhance its leadership position on the 'moving beyond smoking' front. PM is increasing its activity in the US, which is likely to hurt competition, including MO. The Company outpaces other players, setting the stage with IQOS launch and increasing ZYN manufacturing capacity in the US to accomplish the goal of reaching a 10% market share.
Will Philip Morris (PM) Beat Estimates Again in Its Next Earnings Report?
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is Philip Morris International (PM) Outperforming Other Consumer Staples Stocks This Year?
Here is how Philip Morris (PM) and Pilgrim's Pride (PPC) have performed compared to their sector so far this year.
Philip Morris Analyst Raises Forecasts Ahead Of Q3 Earnings, But 'Consumer Elasticities Remain A Risk'
Tobacco giant Philip Morris International Inc. PM invested $232 million to expand its Kentucky facility.
Innovation Titan Philip Morris International Comes To America
Philip Morris is entering the US market, poised to capture significant market share in smoke-free products, challenging Altria and British American Tobacco. PM's strong focus on smoke-free products, with 38% of revenue from SFPs, positions it as a leader in the industry's future. Despite lower dividends compared to competitors, PM's total return and growth potential make it a compelling investment.
What Does Philip Morris's Sale of Vectura Group Mean for its Future? (Revised)
PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.
Philip Morris Stock Trading Above 200 & 50-Day SMA: Should You Buy?
Philip Morris is poised for success, bolstered by its robust momentum, commitment to innovative smoke-free solutions and ability to drive profitability.
Billionaire Stanley Druckenmiller Just Added This Hot Dividend Growth Stock to His Portfolio
Philip Morris International is one of the new large positions in Stanley Druckenmiller's family office portfolio. The company is set to grow earnings with the growth of its new-age nicotine product portfolio.
What Does Philip Morris's Sale of Vectura Group Mean for its Future?
PM sells Vectura Group to Molex Asia Holdings amid criticism of its ownership as it seeks to shift from tobacco to healthcare.
Philip Morris to sell stake in pharma unit Vectura for $198 mln
Marlboro maker Philip Morris International's unit Vectura Fertin Pharma said on Tuesday it would sell its subsidiary Vectura Group to Molex Asia Holdings for 150 million pounds ($198.09 million).
